Completed PHASE4 INTERVENTIONAL 2-arm NCT01103154

A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding (Carvedilol)

A Controlled Trial of Nadolol Plus Isosorbide Mononitrate vs. Carvedilol for the Prevention of Variceal Rebleeding

Sponsor: E-DA Hospital

Updated 6 times since 2017 Last updated: Oct 24, 2010 Started: Mar 31, 2005 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Variceal Rebleeding and is currently completed. E-DA Hospital leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Jun 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Jun 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

E-DA Hospital
National Science and Technology Council, Taiwan

Data source: E-DA Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.